Dexcom says gets FDA OK to calibrate glucose monitoring system

Nov 16 (Reuters) - DexCom Inc (DXCM.O) said it has received approval to calibrate its seven-day continuous glucose monitoring system using any blood glucose meter cleared by the Food and Drug Administration. DexCom said with the approval patients will be able to calibrate the system without using a connection cable.

The medical device company said in a statement that it expects to launch this feature to new patients near the end of the first quarter of 2008 and upgrade existing patients during the second quarter of 2008. (Reporting by Sreerupa Mitra in Bangalore; Editing by Bernard Orr)